Daniel Chester Buck, DPM | |
15 Gracelawn Rd Ste 101, Auburn, ME 04210-6347 | |
(207) 333-4710 | |
(207) 333-4715 |
Full Name | Daniel Chester Buck |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 38 Years |
Location | 15 Gracelawn Rd Ste 101, Auburn, Maine |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972580009 | NPI | - | NPPES |
P00260831 | Other | ME | RR MEDICARE |
129670099 | Medicaid | ME |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | POD194 (Maine) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Mary's Regional Medical Center | Lewiston, ME | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Marys Regional Medical Center | 0042107120 | 203 |
News Archive
Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness.
Researchers from Monash University, Australia will study the long-term health effects of pesticide use focusing on fruit growers in the Goulburn Valley.
Current hospital cleaning protocol may be inadequate to rid patient rooms of multidrug-resistant (MDR) Acinetobacter baumannii, according to a study in the December issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Flexion Therapeutics today announced agreements with four major pharmaceutical partners, acquiring the rights to four clinical-stage compounds, and gaining investment from the world's biggest pharmaceutical company.
› Verified 9 days ago
Provider Name | St Marys Regional Medical Center |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1447226584 PECOS PAC ID: 0042107120 Enrollment ID: O20040303000236 |
News Archive
Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness.
Researchers from Monash University, Australia will study the long-term health effects of pesticide use focusing on fruit growers in the Goulburn Valley.
Current hospital cleaning protocol may be inadequate to rid patient rooms of multidrug-resistant (MDR) Acinetobacter baumannii, according to a study in the December issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Flexion Therapeutics today announced agreements with four major pharmaceutical partners, acquiring the rights to four clinical-stage compounds, and gaining investment from the world's biggest pharmaceutical company.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Daniel Chester Buck, DPM Po Box 95000 Lbx 7650, Philadelphia, PA 19195-0001 Ph: () - | Daniel Chester Buck, DPM 15 Gracelawn Rd Ste 101, Auburn, ME 04210-6347 Ph: (207) 333-4710 |
News Archive
Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness.
Researchers from Monash University, Australia will study the long-term health effects of pesticide use focusing on fruit growers in the Goulburn Valley.
Current hospital cleaning protocol may be inadequate to rid patient rooms of multidrug-resistant (MDR) Acinetobacter baumannii, according to a study in the December issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Flexion Therapeutics today announced agreements with four major pharmaceutical partners, acquiring the rights to four clinical-stage compounds, and gaining investment from the world's biggest pharmaceutical company.
› Verified 9 days ago
Steven Gershman, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 280 Minot Ave, Auburn, ME 04210 Phone: 207-786-4430 | |
Christopher E. Sacco, Dpm, Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 280 Minot Ave, Auburn, ME 04210 Phone: 207-782-2256 Fax: 207-514-7651 |